Mitra, Doyel <br/><br/>
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance.  [electronic resource] 

 -  Molecular cancer therapeutics  Aug 2009 
 - 2152-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-09-0295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fluorescent Antibody Technique<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Mice<br/>NIH 3T3 Cells<br/>Protein Isoforms--genetics<br/>Receptor, ErbB-2--genetics<br/>Signal Transduction<br/>Transfection<br/>Trastuzumab